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INTRODUCTION
Keratoconus is a noninflammatory cone-like ectasia of the cornea 
that can be managed by glasses, contact lenses, keratoplasty, cross- lin -
king (CXL)(1), and intrastromal corneal ring segment (ICRS)(2-3) insertion, 
based on the stage of the disease and the patient’s symptoms. Despite 
being an evolutive disease, CXL has recently been utilized as a thera-
peutic option for stabilizing the cornea(1).
An optical microscopic study(4) demonstrated that the morpho-
logy grade of the most superficial epithelial cells obtained by impres-
sion cytology (IC) from the cornea and bulbar conjunctiva did not 
change after CXL using riboflavin and ultraviolet-A (UVA) light in the 
treat ment of keratoconus.
Some patients have been pretreated with CXL, and ICRS can be 
performed in conjunction to the produce, flattening the central cor-
neal curvature, which decreases corneal irregularity and improves vi-
sual acuity(5). To the authors’ knowledge, no report on the cytological 
features of the ocular surface epithelium after CXL and ICRS insertion 
in the treatment of keratoconus currently exists in the literature.
The aim of this study was to report the IC features of the conjun cti va 
and cornea after CXL and ICRS insertion in the treatment of keratoco-
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ABSTRACT
Purpose: To report the impression cytologic results after corneal cross-linking and 
insertion of intrastromal corneal ring segments for keratoconus.
Methods: Thirty-nine eyes were distributed into two groups: 1) cross-linking group 
(patients underwent corneal cross-linking procedure), and 2) riboflavin eyedrops group 
(patients received 0.1% riboflavin (w/v) eyedrops in 20% dextran solution for 1 month). 
After 3 months, all patients underwent insertion of intrastromal corneal ring segments. 
Impression cytologic specimens were obtained from all eyes at baseline, at 1 month 
and 3 months after cross-linking or riboflavin eyedrops, and again at 6 months, 1 year, 
and 2 years after intrastromal corneal ring segment insertion.
Results: Patients in the cross-linking group demonstrated improvement in the cell- 
to-cell contact of epithelial cells and the nucleus-to-cytoplasm ratio on the temporal 
conjunctiva after treatment (P=0.008 and P=0.047), respectively. On the superior con-
junctiva, increases in goblet cell density (P=0.037) and level of organization of nuclear 
chromatin (P=0.010) after treatment were noted. Patients in the riboflavin eyedrops 
group demonstrated improvement in the cell-to-cell contact of epithelial cells on 
the superior conjunctiva after treatment (P=0.021). On the temporal conjunctiva, an 
improvement in the cell-to-cell contact of epithelial cells (P<0.001) and increases in the 
nucleus-to-cytoplasm ratio (P<0.001), goblet cell density (P=0.001), and less keratiniza-
tion (P=0.011) were noted. No changes were identified on the cornea for either group. 
Fisher’s exact test comparison of the impression cytologic total scores after treatment 
revealed no difference between groups. 
Conclusion: Despite changes in some conjunctival parameters (e.g., cell-to-cell con tact 
of epithelial cells, nucleus-to-cytoplasm ratio, level of organization of nuclear chro matin, 
goblet cell density, and keratinization), comparison of the total impression cytologic 
scores revealed no difference between groups.
Keywords: Cytological techniques; Cornea; Riboflavin; Keratoconus; Corneal surgery, 
laser; Corneal stroma
RESUMO
Objetivo: Relatar os resultados de citologia de impressão após o “cross-linking” da córnea 
e inserção dos segmentos de anéis corneanos intraestromais para ceratocone.
Métodos: Trinta e nove olhos foram distribuídos em dois grupos: pacientes no grupo 
cross-linking foram submetidos ao procedimento do “cross-linking” corneano e pacientes 
no grupo colírio de riboflavina receberam o colírio de riboflavina 0,1% (w/v) -20% dextran 
para uso tópico por um mês. Após três meses, todos os pacientes foram submetidos à 
inserção dos segmentos de anéis corneanos intraestromais. Citologia de impressão foi 
realizada em todos os olhos no pré-operatório, um mês e três meses após o “cross-linking” 
ou colírio de riboflavina, e novamente com seis meses, um ano e dois anos após a inserção 
dos segmentos de anéis.
Resultados: Pacientes do grupo “cross-linking” apresentaram melhora na adesividade 
das células epiteliais e proporção núcleo: citoplasma na conjuntiva temporal após o trata-
mento (P=0,008 e P=0,047), respectivamente. Na conjuntiva superior, houve um aumento na 
densidade das células caliciformes (P=0,037) e nível de organização da cromatina nuclear 
(P=0,010) após o tratamento. Pacientes do grupo colírio de riboflavina apresentaram melhora 
na adesividade das células epiteliais na conjuntiva superior após o tratamento (P=0,021). 
Na conjuntiva temporal, houve melhora na adesividade das células epiteliais (P<0,001), 
aumento na proporção núcleo: citoplasma (P<0,001), células caliciformes (P=0,001) e menor 
queratinização (P=0,011). Ambos os grupos não apresentaram alterações corneanas. O 
Teste exato de Fisher para comparação de citologia de impressão no escore total após o 
tratamento não revelou diferença entre os grupos.
Conclusão: Apesar de mudanças em alguns parâmetros conjuntivais (adesividade das 
células epiteliais, proporção núcleo:citoplasma, nível de organização da cromatina nu-
clear, células caliciformes e queratinização), a comparação do escore total na citologia 
de impressão não apresentou diferença entre os grupos.
Descritores: Técnicas citológicas; Córnea; Riboflavina; Ceratocone; Cirurgia da córnea a 
laser; Substância própria
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nus and to compare the results with those patients presenting with 
similar stages of the same disease.
METHODS
An interventional prospective randomized clinical trial was con -
ducted between March 2008 and December 2010 at the Vision Insti-
tute, Department of Ophthalmology, Federal University of São Paulo, 
São Paulo, Brazil. This study was approved by the Institutional Ethics 
Committee and conducted according to the tenets of the Declara-
tion of Helsinki. All patients provided informed consent.
Patients diagnosed with documented keratoconus with a cor neal 
thickness of at least 400 µm and a history of intolerance to contact 
lens fitting were recruited for the study. Exclusion criteria included 
previous ocular surgery; only one functional eye; corneal opacity on 
the axis; corneal curvature >65 diopters; history of herpetic keratitis; 
moderate dry eye; autoimmune disease; and pregnancy. The criteria 
for the diagnosis of dry eye included tear film, punctacte keratitis, 
and patient complaint.
A total of 39 eyes of 31 patients were included. All eyes were 
gra ded according to the Amsler-Krumeich classification(6), based 
on patient’s refraction, mean central K-reading, corneal signs, and 
corneal thickness. All treated eyes were graded stage II or III. Using a 
randomized table, patients were distributed into two study groups 
according to the treatment: CXL group (19 eyes underwent CXL pro -
cedure using riboflavin and UVA light) and riboflavin eyedrops (RE) 
group (20 eyes received 0.1% riboflavin (wt/vol) eyedrops [10 mg 
ri boflavin-5-phosphate in 20% (wt/vol) dextran-T-500; Ophthalmos, 
São Paulo, Brazil] 4 times per day for 1 month.
In eight patients, both eyes were included. In these eight cases, 
the right eye received only RE, and the left eye underwent the CXL 
procedure. After 3 months of this first step (CXL or RE), all patients 
then underwent insertion of ICRS (Keraring, Mediphacos, Belo Hori-
zonte, Brazil), which comprised the second step.
Clinical data collected included patients’ demographic features 
(e.g., age, race, and gender). All patients underwent routine ophthal -
mo logic evaluation (uncorrected distance visual acuity and correc ted 
distance visual acuity assessment, slit-lamp biomicroscopy, Gol d mann 
applanation tonometry, and ocular fundus examination), corneal 
topography (EyeSys-2000 Corneal Topography instrument; EyeSys 
Vi sion, Irvine, CA), Orbscan IIz examination (Bausch & Lomb Gmbh, 
Feldkirchen, Germany), Pentacam examination (Oculus Optik ge rate 
Gmbh, Wetzlar, Germany), Visante Optical Coherence Tomography 
(OCT; Carl Zeiss Meditec, Dublin, CA), and IC before treatment and at 
1 month and 3 months after CXL or RE, and again at 6 months, 1 year, 
and 2 years after ICRS insertion.
IC teChnIque
After the slit-lamp examination, all patients were subjected to IC 
sampling by the same researcher (A.C.R.). Following the application of 
topical anesthesia, IC specimens were collected (Millipore HAWP304; 
Bedford, MA) from the four quadrants of the cornea, from an expo-
sed area of the bulbar conjunctiva (temporal region), and from an 
unexposed area of the conjunctiva (superior region) adjacent to the 
corneal limbus. All strips were processed for periodic acid-Schiff and 
Gill hematoxylin staining. Glass slides mounted with Entellan (Merck, 
Darmstadt, Germany) were analyzed under light microscopy by an 
experienced professional (J. N. B.), operating in a masked fashion. For 
quality control, only IC specimens with at least one-third of the filter 
surface covered with visible epithelial cells were included.
Conjunctival samples were evaluated according to established 
techniques for the following parameters(7-9): cellularity, cell-to-cell 
contact of epithelial cells, nucleus-to-cytoplasm (N:C) ratio, nuclear 
chromatin level, goblet cell density, keratinization, and distribution of 
inflammatory cells. A score of 0 to 3 was assigned to each of these fea-
tures. Zero represented normal findings. One represented borderline 
features, and 2 or 3 represented abnormal features. The scores obtai-
ned for each parameter were added together to obtain a total score 
and classified as A or normal (total score 0-3), B or borderline (total 
score 4-6), and C or abnormal (total score >6). Goblet cell densities 
were judged as normal when abundant, borderline when slightly or 
moderately reduced, and abnormal when distinctly reduced (single 
to no goblet cells). Corneal samples were evaluated and graded 
according to the squamous metaplasia classification proposed by 
Murube and Rivas(10).
Cross-lInkIng proCedure
The cross-linking procedure in the CXL group was performed by 
the same surgeon (M.C.) according to the standard protocol(11). 0.5% 
proxymetacaine hydrochloride (wt/vol) eyedrops were applied. After 
a 9-mm diameter abrasion of the corneal epithelium, drops of a 0.1% 
riboflavin solution (wt/vol) in 20% dextran were applied onto the 
cornea every 5 minutes for a total of 30 minutes. Using a slit lamp 
with a blue filter, the surgeon confirmed the presence of riboflavin 
in the anterior chamber before UVA irradiation commenced. The 
cornea was exposed (using a lid speculum) to UV light (UV-X System; 
Peschke Meditrade GmbH, Hunenberg, Switzerland), which emits 
light at a wavelength of 370 ± 5 nm at an irradiance of 3 mW/cm2 or 
5.4 J/cm2 for 30 minutes (medium spot). During this time, riboflavin 
solution was applied every 5 minutes. The limbus and conjunctiva 
were not protected during irradiation. Topical anesthetic was applied 
as required during the surgery.
After the treatment, a soft bandage contact lens was applied until 
reepithelialization was complete. A combination of 0.5% moxifloxa-
cin (wt/vol) and 0.1% dexamethasone phosphate (wt/vol) eyedrops 
(Alcon Laboratories, Fort Worth, TX) was prescribed q.i.d. for 2 weeks. 
Intrastromal Corneal rIng segment ImplantatIon
Intrastromal corneal ring segment implantation was performed 
by one of the authors (M.C.) in an operating room under sterile con-
ditions using topical anesthetic drops. The Purkinje reflex was chosen 
as the central point and marked under a biomicroscope. A 5.0-mm 
marker was used to locate the exact ring channel. Tunnel depth was 
set at 80% of the thinnest corneal thickness on the tunnel location.
The arc length and thickness were chosen according to the 
manufacturer’s nomogram. A 60-kHz femtosecond laser (IntraLase 
Corp, Irvine, CA) was used to create the ring channels. The channel’s 
inner diameter was set to 5.0 mm, and the outer diameter was set to 
5.9 mm. The entry-cut thickness was 1 µm, and the ring energy for 
channel creation was 1.70 µJ. The entry-cut energy was 1.10 µJ, and 
channel creation timing with the femtosecond laser was 15 seconds. 
The ICRS was implanted immediately after channel creation and 
before the disappearance of the bubbles, which revealed the exact 
tunnel location.
Postoperatively, a combination of 0.5% moxifloxacin (wt/vol) and 
0.1% dexamethasone phosphate (wt/vol) eyedrops (Alcon Laborato-
ries) was prescribed q.i.d for 2 weeks. The patients were instructed to 
avoid rubbing their eyes and to use artificial tears frequently. On the 
first postoperative day, slit-lamp biomicroscopic examination was 
performed. Wound healing and segment migration were evaluated.
Follow-up IC examinations were scheduled at baseline, at 1 mon-
th and 3 months after CXL or RE, and again at 6 months, 1 year, and 
2 years after ICRS insertion.
statIstICal analysIs
Fisher’s exact test was applied to evaluate the IC grades. The Fried -
man test was used to compare evaluations made at baseline, at 1 
month and 3 months after CXL or RE, and again at 6 months, 1 year, 
and 2 years after ICRS insertion. Calculations were performed using 
the statistical software Minitab version 15.1 (Minitab, Inc., State Colle-
ge, PA). The level of statistical significance was set at P<0.05.
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RESULTS
Of the 31 patients, 23 were women (74.19%) and 8 were men 
(25.80%). The mean ages of the patients were 28.30 ± 9.3 years (ran-
ge, 17-55 years) in the CXL group and 30.40 ± 9.1 years (range, 22-55 
years) in the RE group. Both groups were similar before treatment, as 
assessed by corneal keratometry (flattest-K1 and steepest-K2 meri-
dian) and spherical equivalent measurements (Table 1).
Table 2 summarizes the IC results. When IC was compared bet -
ween the two groups (Table 3), no significant difference was obser-
ved at any time point. According to the Friedman test, a significant 
difference by IC was identified when certain parameters were com-
pared over time. Improvement in cell-to-cell contact of epithelial 
cells (P=0.008) (Figure 1A) and in the nucleus-to-cytoplasm (N:C) 
ratio (P=0.047) (Figure 1B) on the temporal conjunctiva in the CXL 
group was noted. On the superior conjunctiva, increases in goblet 
cell density (P=0.037) (Figure 2A) and level of organization of nuclear 
chromatin (P=0.010) (Figure 2B) after treatment were observed. In 
the RE group, improvement in cell-to-cell contact of epithelial cells 
on the superior conjunctiva (P=0.021) (Figure 3) after treatment was 
noted. On the temporal conjunctiva, an improvement in cell-to-cell 
contact of epithelial cells (P<0.001) (Figure 4A), and increases in the 
N:C ratio (P<0.001) (Figure 4B), goblet cell density (P=0.001) (Figure 
Table 1. Topographic results (D) and spherical equivalent (D)
Group Measure N Mean SD Minimum Median Maximum P
CXL K1 19 48.10 4.21 41.41 47.50 55.87 0.197
0.454
0.090
RE K1 20 46.50 3.39 41.66 46.29 54.87
CXL K2 19 53.26 5.11 43.10 52.98 61.25
RE K2 20 52.17 3.89 45.06 51.09 63.92
CXL SE 19 --7.41 3.48 -14.00 -6.50 -1.75
RE  SE 20 --5.45 3.53 -13.50 -4.50 00.75
D= diopters; N= number of eyes; P= significance level (t test); SD= standard deviation; CXL= cross-linking group; RE= riboflavin eyedrops group; SE= spherical equivalent; K1= minimum 
keratometry; K2= maximum keratometry
Table 3. Fisher’s exact test to compare conjunctival total scores between the two groups
P
Region Pre-treatment 1 month 3 months 6 months 1 year 2 years
Superior 0.174 0.147 0.069 0.500 - 0.285
Temporal 0.255 0.216 0.109  0.399 0.374 0.541
 Table 2. Impression cytologic (IC)
 Total score
 corneal class
A
N (%)
B
N (%)
C
N (%)
 Total score 
 superior class  
A
N (%)
B
N (%)
C
N (%)
Total score 
temporal class 
A
N (%)
B
N (%)
C
N (%)
P* 
CXL=0.251 
RE=0.042
P*  
CXL=0.359 
RE=0.018
Pretreatment Pretreatment  Pretreatment 
CXL 
RE
19 (100.0)
20 (100.0)
-
-
-
-
CXL
RE 
17 (094.4)
16 (080.0)
1 (05.6)
3 (15.0)
-
1 (5.0)
 CXL
 RE 
11 (064.7)
12 (060.0)
5 (29.4)
6 (30.0)
1 (05.9)
2 (10.0)
1 month 1 month 1 month
CXL  
RE
19 (100.0)
20 (100.0)
-
-
-
-
CXL
RE
15 (078.9)
18 (094.7)
4 (21.1)
1 (05.3)
-
-
CXL 
RE
14 (073.7)
12 (063.2)
5 (26.3)
6 (31.6)
-
1 (05.3)
3 months 3 months 3 months
CXL
RE
18 (100.0)
20 (100.0)
-
-
-
-
CXL
RE 
12 (070.6)
17 (094.4)
5 (29.4)
1 (05.6)
-
-
CXL 
RE
14 (087.5)
16 (084.2)
1 (0.6.3) 
3 (15.8)
1 (06.3) 
-
6 months 6 months 6 months
CXL 
RE
16 (094.1)
19 (100.0)
1 (5.9)
-
-
-
CXL
RE
16 (094.1)
17 (100.0)
1 (05.9)
-
-
-
CXL
RE
15 (093.8)
15 (088.2)
1 (0.6.3)
2 (11.8)
-
-
1 year 1 year 1 year
CXL
RE
18 (100.0)
19 (100.0)
-
-
-
-
CXL
RE
18 (100.0)
19 (100.0)
-
-
-
-
CXL
RE
15 (088.2)
17 (094.4)
2 (11.8)
1 (0.5.6)
-
-
2 years 2 years 2 years
CXL
RE
15 (093.8)
19 (100.0)
1 (6.3)
-
-
-
CXL
RE
17 (100.0)
18 (090.0)
-
1 (05.0)
-
1 (5.0)
CXL
RE
17 (100.0)
19 (095.0)
-
1 (0.5.0)
-
-
N= number of eyes; CXL= cross-linking group; RE= riboflavin eyedrops group; P*= Friedman test was used to compare IC results before treatment, 1, 3, and 6 months, and at 
1 and 2 years
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4C), and less keratinization (P=0.011) (Figure 4D) were observed. In 
both groups, the IC corneal features remained stable with a comple-
tely normal presentation both before treatment and at all follow-up 
times.
DISCUSSION
In the present study, the ocular surface of two groups of patients 
who underwent ICRS insertion was evaluated by IC. The IC technique 
studies the most superficial layers of cells from the corneal and con-
junctival surfaces(12). Morphological changes in the bulbar conjuncti-
va do not always occur in typical combinations. Therefore, a grading 
system (IC score) that included several morphological parameters (IC 
subscores) was devised to provide a complete analysis of conjuncti-
val alteration. The parameters were separately judged and totaled to 
yield the final score, as described elsewhere(8-9).
Recently, an optical microscopic study(4) by our group demons-
trated that despite changes in goblet cell density after corneal CXL in 
the superior conjunctiva and an improvement in the morphology of 
epithelial cells after the use of RE, the morphology grade of the most 
superficial epithelial cells obtained by IC from the cornea and bulbar 
conjunctiva did not change after CXL using riboflavin and UVA light 
in the treatment of keratoconus. This finding suggests that the CXL 
is a safe procedure at the 3-month follow-up. The ICRS had not been 
inserted at this time point.
Now, new results from a 2-year follow-up period showed im-
provements in the cell-to-cell contact of epithelial cells and the N:C 
ratio on the temporal conjunctiva in the CXL group. On the superior 
conjunctiva, an increase in the values of nuclear chromatin and goblet 
cells were observed at the 2-year follow-up. The conjunctival goblet 
cell count and the epithelial cell morphology are objective measures 
of the ocular surface status. The goblet cells are responsible for the 
production of gel-forming mucin, MUC5AC, whereas corneal and 
conjunctival epithelial cells synthesize transmembrane mucins, such 
as MUC1, 2, and 4. The gel-forming mucin constitutes the main com-
ponent of the mucus layer (innermost component of the film)(13), and 
it stabilizes the tear film.
In a previous study(4), a reduction in goblet cell density on the su-
perior conjunctiva was observed after the CXL. The follow-up period 
was only 3 months, and the authors related this finding to factors 
such as the toxicity of the topical medication and inflammation or 
mechanical damage from the lid speculum. In the present study, the 
effect of the CXL procedure on the cells layer from the cornea was 
not present anymore. The durability of the stiffening effect of the CXL 
is unknown; however, the collagen turnover in the cornea is estima-
ted between 2 to 3 years(1). Previous reports using IC have shown a 
gre ater reduction in goblet cells after femtosecond laser treatment 
than after mechanical microkeratomy in LASIK procedures due to 
the length of time that the suction ring exerts pressure on the con-
A B
Figure 1. A) Cross-linking group: cell-to-cell contact of epithelial cells - temporal conjunctiva. B) Cross-linking group: nucleus-to-cytoplasm ratio -  temporal 
conjunctiva.
Figure 2. A) Cross-linking group: goblet cell density - superior conjunctiva. B) Cross-linking group: nuclear chromatin level - superior conjunctiva.
A
B
Figure 3. Riboflavin eyedrops group: cell-to-cell contact of epithelial cells - 
superior conjunctiva.
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junctiva. The destruction of corneal tissue by LASIK procedures may 
also directly or indirectly affect the population of goblet cells. These 
findings were observed at the 3-month follow-up. After 6 months, 
the goblet cells recovered(14), which was similar to our experience. 
In our study, the femtosecond laser was used to create the channel 
ring at a depth of 80% of the thinnest corneal thickness on the tunnel 
location. Thus, the creation of the channel ring by the femtosecond 
laser did not affect the goblet cell density on the ocular surface in 
our group of patients.
In the present study, the IC results before and after treatment 
were normal (grade 0) in all corneal specimens. Although epithelial 
debridement before corneal CXL can cause necrosis and apoptosis(15) 
of keratocytes at a depth of 50 to 60 μm, any significant cytotoxic 
effect of CXL seems to be concentrated in the anterior part of the 
cornea because of the high absorption of UVA light by riboflavin. This 
behavior prevents the light from penetrating to deeper levels and 
preserves the endothelium and lens. Previous reports showed neither 
clinically evident side effects of CXL treatment nor persistent epithe-
lial defects(16), with the exception of transient corneal edema and a 
foreign body sensation for 24-48 hours, in combination with burning 
and tearing that are common in photorefractive surgery. Mazzotta 
et al.(16) used confocal microscopy to demonstrate that the cytotoxic 
effects of CXL, although significant, were concentrated in the first 
350 μm of the stroma and did not affect the adjacent structures.
In the riboflavin eyedrops group, an improvement in the cell-to- 
cell contact of epithelial cells on superior conjunctiva was noted at the 
2-year follow-up. On the temporal conjunctiva, improvements in the 
cell-to-cell contact of epithelial cells and keratinization, and increases 
in the N:C ratio and goblet cell density were noted. Our patients used 
riboflavin eyedrops for 1 month, and the aforementioned parameters 
improved up to the 2-year follow-up. These findings are possibly rela-
ted to the more regular use of artificial tears prescribed throughout 
the 2-year follow-up period. These patients were followed closely and 
encouraged to regularly use the artificial tears. Squamous metaplasia 
scores may have improved in the conjunctiva because of a rise in 
ocular surface humidity related to the regular use of artificial tears 
over time.
Riboflavin alone produced no cell damage, which is not surpri-
sing because riboflavin is also present in the retina, liver, and heart as 
an essential element in normal nutrition(17). In a previous experimen-
tal study, riboflavin played a role in the development and maintenan-
ce of the surface structures of epithelial cells(18).
CONCLUSION
Cross-linking and intrastromal corneal ring segment insertion did 
not change the ocular surface morphology grade in keratoconic eyes 
as assessed by impression cytologic analysis.
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